#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hairy cell leukaemia recurrent Autoimmune demyelinating disease Congenital growth hormone deficiency Liver abscess Huntington's disease Anti-myelin-associated glycoprotein associated polyneuropathy Erythema Pancreatic neuroendocrine tumour Selective polysaccharide antibody deficiency Hypochromic anaemia Pleomorphic leiomyosarcoma Waldenstrom's macroglobulinaemia Non-small cell lung cancer recurrent Ovarian cancer stage III Metachromatic leukodystrophy More trials…

    Learn about Rare Diseases

    Lennox-Gastaut syndrome – Trials in Disease Glycogen storage disease type V – Diagnostics Haemophilia B without inhibitors Inclusion body myositis – Trials in Disease Glycogen storage disease type I – Treatment MELAS syndrome Inclusion body myositis – Diagnostics Advanced systemic mastocytosis – Diagnostics Glomerulonephritis membranous – Treatment Cystic fibrosis lung – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Taletrectinib Pegcetacoplan Ganciclovir Sodium Itolizumab Lanreotide Betula Verrucosa Pollen Ianalumab Ro7269162 Cisatracurium Besilate Ict01 Dazodalibep Fluticasone Furoate Posdinemab PEGZILARGINASE Miransertib Ruxotemitide Dextromethadone Hydrochloride Doxecitine Cat Epithelium Extract Cldn6 Car-T More therapies…

    Learn about Your Condition

    Acne Rhabdoid tumour of the kidney Hypertonic bladder Breast angiosarcoma metastatic Polycythaemia vera Anal cancer metastatic Cholangiocarcinoma Laparotomy Mitral valve disease Hydrocele Hyperparathyroidism primary Lennox-Gastaut syndrome Sepsis Alcohol use disorder Osteotomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Study on the Effects of Upadacitinib for Patients with Active Psoriatic Arthritis and Axial Spondyloarthritis

    Recruiting

    3 1
    Investigated Diseases:
    • Axial spondyloarthritis
    • Psoriatic arthropathy
    Investigated Drugs:
    • Upadacitinib
    Belgium Poland

  • Study on Frozen Shoulder: Evaluating the Effectiveness of Physiotherapy, Triamcinolone Acetonide, and Lidocaine in Improving Shoulder Function and Reducing Pain

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Periarthritis
    Investigated Drugs:
    • Cetrimide
    • Lidocaine
    • Triamcinolone Acetonide
    Norway

  • Study on Long-Term Safety and Efficacy of VX-670 for Adults with Myotonic Dystrophy Type I

    Recruiting

    1 1 1
    Investigated Drugs:
    • Vx-670
    Belgium France Germany Italy The Netherlands Spain

  • Study on Immune Response to Recombinant Zoster Vaccine in Rheumatic Disease Patients Using Baricitinib, Tofacitinib, or Methotrexate

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatic disorder
    Investigated Drugs:
    • Recombinant Varicella Zoster Virus Glycoprotein E
    • Baricitinib
    • Filgotinib
    France

  • Study on the Effects and Safety of Rituximab and Sodium Chloride in Patients with Active Systemic Sclerosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Sodium Chloride
    • Rituximab
    The Netherlands

  • Study on IPN10200 for Treating Cervical Dystonia in Adults

    Recruiting

    2 1
    Investigated Drugs:
    • Clostridium Botulinum, Neurotoxin Serotype A/B
    Czechia France Germany Italy Poland Spain
Previous Page
1 … 5 6 7 8 9 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!